Vigil Neuroscience, Inc. (VIGL) - Quarterly Income Statement

Home
VIGL
Financials

8.05 (USD) • At close August 5, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2
Revenue Numbers are in millions	0	0	0.452	0	0	0	1.934	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0.124	0.226	0.114	0.113	0.113	0.113	0.11	0.474	0.383	0.274	0.253	0.246	0.237	0	0.151	0	0	0	0	0
Gross Profit Numbers are in millions	0	-0.124	0.226	-0.114	-0.113	-0.113	-0.113	-0.11	-0.474	-0.383	-0.274	-0.253	-0.246	-0.237	0	-0.151	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0.5	0	0	0	-0.058	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	17.41	16.511	18.668	13.772	15.54	14.326	16.782	15.415	14.903	13.834	12.191	12.791	12.097	10.365	9.119	7.81	8.648	6.753	3.177	22.26	0.197
General & Administrative Expenses Numbers are in millions	10.081	6.958	6.446	6.904	6.938	7.089	7.075	6.906	7.01	6.941	6.682	4.846	4.945	4.967	3.858	2.928	2.128	1.165	0.882	0.895	0
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	-0.113	-0.113	-0.113	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	10.081	6.958	6.446	6.904	6.825	6.976	6.962	6.906	7.01	6.941	6.682	4.846	4.945	4.967	3.858	2.928	2.128	1.165	0.882	0.895	0.184
Other Expenses Numbers are in millions	0	0	0	0	0	0	0	0	-0.007	-0.005	-0.009	-0.026	-0.005	-0.004	-0.008	-0.002	0	0	0	0	0
Operating Expenses Numbers are in millions	27.491	23.469	25.114	20.676	22.365	21.302	23.744	22.321	21.913	20.775	18.873	17.637	17.042	15.332	12.977	10.738	10.776	7.918	4.059	23.155	0.381
Operating Income Numbers are in millions	-27.491	-23.469	-25.114	-20.676	-22.478	-21.415	-23.857	-22.321	-21.913	-20.775	-18.873	-17.637	-17.042	-15.332	-12.977	-10.738	-10.776	-7.918	-4.059	-23.155	-0.381
Operating Income Ratio Numbers are in millions	0	0	-55.562	0	0	0	-12.336	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	0.828	1.056	1.283	1.418	1.251	1.475	1.683	1.826	1.739	0.98	0.417	0.137	0.027	-0.002	-0.008	-0.002	-0.591	-0.273	-0.177	-1.155	0
Income Before Tax Numbers are in millions	-26.663	-22.413	-23.831	-19.258	-21.227	-19.94	-22.174	-20.495	-20.174	-19.795	-18.456	-17.5	-17.015	-15.334	-12.985	-10.74	-11.367	-8.191	-4.236	-24.31	-0.381
Income Before Tax Ratio Numbers are in millions	0	0	-52.723	0	0	0	-11.465	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	0	0	0	0	-0.11	0	-1.045	-32.791	-0.137	-0.027	0.002	0	0.002	0	0	0	0	0
Net Income Numbers are in millions	-26.663	-22.413	-23.831	-19.258	-21.227	-19.94	-22.174	-20.495	-20.174	-18.75	14.335	-17.363	-16.988	-15.336	-12.985	-10.74	-11.367	-8.191	-4.236	-24.31	-0.381
Net Income Ratio Numbers are in millions	0	0	-52.723	0	0	0	-11.465	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.56	-0.49	-0.57	-0.47	-0.52	-0.5	-0.57	-0.53	-0.52	-0.49	0.37	-0.52	-0.6	-0.58	-0.46	-0.38	-0.54	-0.39	-0.2	-1.15	-0.014
EPS Diluted Numbers are in millions	-0.56	-0.49	-0.57	-0.47	-0.52	-0.5	-0.57	-0.53	-0.52	-0.49	0.37	-0.52	-0.6	-0.58	-0.46	-0.38	-0.54	-0.39	-0.2	-1.15	-0.014
EBITDA Numbers are in millions	-27.491	-22.289	-25.001	-20.562	-22.365	-21.302	-23.744	-22.211	-21.802	-20.71	-18.852	-17.616	-17.024	-15.314	-12.962	-10.726	-10.775	0	0	-23.929	-0.381
EBITDA Ratio Numbers are in millions	0	0	-55.312	0	0	0	-12.277	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Vigil Neuroscience, Inc.

NASDAQ:VIGL Add to watchlist

NASDAQ:VIGL